News

The conquest of San Siro and the Oaks, the classic race he had never won, was achieved by Cristian Demuro riding Klaynn, who ...
MALVERN, Pa., June 17, 2025 /PRNewswire/ -- Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI) today announced that it has completed the previously announced divestiture of its International ...
Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI) today announced that it has completed the previously announced divestiture of its International Pharmaceuticals business, primarily operated ...
Wataru Endo has stated his intention to remain at Liverpool, despite ongoing speculation over his future following a season of limited game time.The 32-year-old midfielder was used sparingly ...
Wataru Endo was not meant to be a Liverpool player. During the club’s midfield overhaul of 2023, Endo was not Liverpool’s first choice. Nor was he their second.
Why Virgil van Dijk’s Backing of Wataru Endo Matters More Than Minutes PlayedLeadership Behind the SpotlightIn an era where football increasingly revolves around data, minutes played, and resale ...
Having made his recent debut in season 2, episode 3 of the anime, here's everything you need to know about Yamato Endo. Disclaimer: This article contains heavy spoilers from the Wind Breaker manga.
Dublin-headquartered Mallinckrodt is taking over smaller rival Endo and planning to list the combined firm on the New York Stock Exchange, the two drugmakers said Thursday.
Mallinckrodt and Endo, pharmaceutical companies that have each encountered business struggles, announced Thursday a $6.7 billion merger that they contend will result in a combined entity with the ...
Mallinckrodt, Endo Merger to Create Diversified Pharmaceuticals Firm Endo’s shareholders will receive $80 million in cash and own 49.9% of the combined company for a pro forma enterprise deal ...
Mallinckrodt Pharmaceuticals plc and Endo Inc. said Thursday they are combining as part of a stock-and-cash deal with an enterprise value of $6.7 billion that will give both companies a roughly 50 ...
The Mallinckrodt-Endo combo will start out with pro forma 2025 revenue of $3.6 billion and pro forma 2025 adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of $1.2 ...